STUD AB Inactive Instrument
STUD AB Share Price Swiss Exchange
Equities
NEVI.B
SE0004020931
Investment Management & Fund Operators
|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| Sales 2022 | 5.83Cr 55.47L 46Cr | Sales 2023 | 3.39Cr 32.31L 27Cr | Capitalization | 2.39Cr 22.73L 19Cr |
|---|---|---|---|---|---|
| Net income 2022 | -5.7Cr -54.25L -45Cr | Net income 2023 | -2.7Cr -25.7L -21Cr | EV / Sales 2022 | 1.03 x |
| Net cash position 2022 | 81.45L 8L 6.47Cr | Net cash position 2023 | 30.86L 3L 2.45Cr | EV / Sales 2023 | 0.61 x |
| P/E ratio 2022 |
-1.18
x | P/E ratio 2023 |
-0.88
x | Employees | - |
| Yield 2022 |
1.52% | Yield 2023 |
-
| Free-Float | 65.43% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 36 | - | |
| Chief Tech/Sci/R&D Officer | 30 | - | |
| Director/Board Member | 45 | 11/12/11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 45 | 11/12/11 | |
David Nylén
BRD | Director/Board Member | 41 | - |
| Director/Board Member | 45 | - |
New Equity Venture International AB is a Sweden-based private equity firm engaged in the investment management industry. The Firm invests in listed and unlisted companies engaged in various industries. Its strategy is to invest through new established subsidiary and to pay with a combination of cash and newly issued shares in each subsidiary. Its portfolio includes Acrinova AB, Robert Friman Int. AB, Stureguld Sverige AB, DB Pharmaceutical, Eyonid Technology AB, Fastout Int. AB and Sjostrand Coffee Int. AB.
Calendar
23/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +9.65% | 3.51TCr | |
| -4.82% | 3.37TCr | |
| 0.00% | 1.84TCr | |
| +1.92% | 525.07Cr | |
| +3.77% | 413.11Cr | |
| +6.88% | 330.91Cr | |
| +22.05% | 283.96Cr | |
| -24.71% | 211.32Cr | |
| +3.52% | 122.8Cr |
- Stock Market
- Equities
- NEVI B Stock
- NEVI.B Stock
